Literature DB >> 32569766

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Daniel M Chopyk1, Arash Grakoui2.   

Abstract

Intestinal barrier dysfunction and dysbiosis contribute to development of diseases in liver and other organs. Physical, immunologic, and microbiologic (bacterial, fungal, archaeal, viral, and protozoal) features of the intestine separate its nearly 100 trillion microbes from the rest of the human body. Failure of any aspect of this barrier can result in translocation of microbes into the blood and sustained inflammatory response that promote liver injury, fibrosis, cirrhosis, and oncogenic transformation. Alterations in intestinal microbial populations or their functions can also affect health. We review the mechanisms that regulate intestinal permeability and how changes in the intestinal microbiome contribute to development of acute and chronic liver diseases. We discuss individual components of the intestinal barrier and how these are disrupted during development of different liver diseases. Learning more about these processes will increase our understanding of the interactions among the liver, intestine, and its flora.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic Liver Disease; Drug Induced Liver Injury; Gut Permeability; Hepatic Disorders; Leaky Gut; Liver Disease; Microbiome; Nonalcoholic Liver Disease; Primary Sclerosing Cholangitis

Mesh:

Year:  2020        PMID: 32569766      PMCID: PMC7502510          DOI: 10.1053/j.gastro.2020.04.077

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  181 in total

Review 1.  Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.

Authors:  Taylor Morrisette; Razieh Kebriaei; Katherine L Lev; Sandra Morales; Michael J Rybak
Journal:  Pharmacotherapy       Date:  2020-01-13       Impact factor: 4.705

2.  SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.

Authors:  Mengting Chen; Suocheng Hui; Hedong Lang; Min Zhou; Yong Zhang; Chao Kang; Xianglong Zeng; Qianyong Zhang; Long Yi; Mantian Mi
Journal:  Mol Nutr Food Res       Date:  2018-12-27       Impact factor: 5.914

Review 3.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

4.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

Authors:  Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

5.  Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

Authors:  Khalidur Rahman; Chirayu Desai; Smita S Iyer; Natalie E Thorn; Pradeep Kumar; Yunshan Liu; Tekla Smith; Andrew S Neish; Hongliang Li; Shiyun Tan; Pengbo Wu; Xiaoxiong Liu; Yuanjie Yu; Alton B Farris; Asma Nusrat; Charles A Parkos; Frank A Anania
Journal:  Gastroenterology       Date:  2016-06-21       Impact factor: 22.682

6.  Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Authors:  Dana Tedesco; Manoj Thapa; Chui Yoke Chin; Yong Ge; Minghao Gong; Jing Li; Sanjeev Gumber; Patrick Speck; Elizabeth J Elrod; Eileen M Burd; William H Kitchens; Joseph F Magliocca; Andrew B Adams; David S Weiss; Mansour Mohamadzadeh; Arash Grakoui
Journal:  Gastroenterology       Date:  2018-02-15       Impact factor: 22.682

7.  Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Andrew Fagan; Edith A Gavis; Zain Kassam; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

8.  Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila.

Authors:  Muriel Derrien; Peter Van Baarlen; Guido Hooiveld; Elisabeth Norin; Michael Müller; Willem M de Vos
Journal:  Front Microbiol       Date:  2011-08-01       Impact factor: 5.640

9.  Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.

Authors:  Runping Liu; Jason D Kang; R Balfour Sartor; Masoumeh Sikaroodi; Andrew Fagan; Edith A Gavis; Huiping Zhou; Phillip B Hylemon; Jeremy W Herzog; Xiaojiaoyang Li; Robert H Lippman; Javier Gonzalez-Maeso; James B Wade; Siddhartha Ghosh; Emily Gurley; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.298

Review 10.  Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.

Authors:  Haiming Hu; Aizhen Lin; Mingwang Kong; Xiaowei Yao; Mingzhu Yin; Hui Xia; Jun Ma; Hongtao Liu
Journal:  J Gastroenterol       Date:  2019-12-16       Impact factor: 7.527

View more
  47 in total

1.  Gut microbiome in liver pathophysiology and cholestatic liver disease.

Authors:  Shengmin Yan; Xiao-Ming Yin
Journal:  Liver Res       Date:  2021-08-08

Review 2.  Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis.

Authors:  Weifeng Zhu; Ying Zhou; Rong Tsao; Huanhuan Dong; Hua Zhang
Journal:  Front Nutr       Date:  2022-05-17

3.  Dietary supplementation with biogenic selenium nanoparticles alleviate oxidative stress-induced intestinal barrier dysfunction.

Authors:  Lei Qiao; Xinyi Zhang; Shanyao Pi; Jiajing Chang; Xina Dou; Shuqi Yan; Xiaofan Song; Yue Chen; Xiaonan Zeng; Lixu Zhu; Chunlan Xu
Journal:  NPJ Sci Food       Date:  2022-06-23

Review 4.  The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Authors:  Timur Liwinski; Melina Heinemann; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2022-05-10       Impact factor: 11.759

5.  Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.

Authors:  Natthaya Chuaypen; Thananya Jinato; Anchalee Avihingsanon; Sakkarin Chirapongsathorn; Supapon Cheevadhanarak; Intawat Nookaew; Yasuhito Tanaka; Pisit Tangkijvanich
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

6.  Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure.

Authors:  Yuting Chen; Jingkang Sun; Xiude Fan; Xiaoyun Wang; Lu Zeng; Xiaoge Zhang; Kun Zhang; Na Li; Qunying Han; Zhengwen Liu
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

7.  Protective Effects of Selenium Nanoparticle-Enriched Lactococcus lactis NZ9000 against Enterotoxigenic Escherichia coli K88-Induced Intestinal Barrier Damage in Mice.

Authors:  Yue Chen; Lei Qiao; Xiaofan Song; Li Ma; Xina Dou; Chunlan Xu
Journal:  Appl Environ Microbiol       Date:  2021-09-15       Impact factor: 4.792

8.  Gut Microbiota Mediates the Therapeutic Effect of Monoclonal Anti-TLR4 Antibody on Acetaminophen-Induced Acute Liver Injury in Mice.

Authors:  Xuewei Sun; Qian Cui; Juan Ni; Xiaoguang Liu; Jin Zhu; Tingting Zhou; HuaYing Huang; Ke OuYang; Yulong Wu; Zhan Yang
Journal:  Microbiol Spectr       Date:  2022-05-10

Review 9.  A review on gut microbiota: a central factor in the pathophysiology of obesity.

Authors:  A L Cunningham; J W Stephens; D A Harris
Journal:  Lipids Health Dis       Date:  2021-07-07       Impact factor: 3.876

Review 10.  Effect of different bile acids on the intestine through enterohepatic circulation based on FXR.

Authors:  Junwei Xiang; Zhengyan Zhang; Hongyi Xie; Chengcheng Zhang; Yan Bai; Hua Cao; Qishi Che; Jiao Guo; Zhengquan Su
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.